Canary Capital launches Staked INJ ETF on Nasdaq

Canary Capital has launched the Staked INJ ETF, trading on the Nasdaq under the ticker INJC, providing investors with regulated exposure to the Injective (INJ) token. Unlike standard spot ETFs, this fund is designed to hold INJ directly and participate in the network’s proof-of-stake system to capture staking rewards.

The fund expects to stake at least 90% of its INJ holdings under normal circumstances, with rewards reflected in the net asset value (NAV). The product features an annual management fee of 1.10% and utilizes BitGo as a custodian. Due to the nature of the Injective network, staked tokens are subject to a 21-day unbonding period, during which they cannot be transferred or withdrawn.

This launch marks a significant milestone for Injective, offering a way for traditional brokerage account holders to access the ecosystem without managing private keys or digital wallets. The move follows a trend of expanding institutional access to specialized blockchain networks through regulated exchange-traded products.